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e identiﬁed and characterized a human
orthologue of Rif1 protein, which in budding
yeast interacts in vivo with the major duplex
telomeric DNA binding protein Rap1p and negatively
regulates telomere length. Depletion of hRif1 by RNA in-
terference in human cancer cells impaired cell growth but
had no detectable effect on telomere length, although
hRif1 overexpression in 
 
S. cerevisiae
 
 interfered with telo-
mere length control, in a manner speciﬁcally dependent
on the presence of yeast Rif1p. No localization of hRif1 on
normal human telomeres, or interaction with the human
telomeric proteins TRF1, TRF2, or hRap1, was detectable.
W
 
However, hRif1 efﬁciently translocated to telomerically lo-
cated DNA damage foci in response to the synthesis of
aberrant telomeres directed by mutant-template telomer-
ase RNA. The hRif1 level rose during late S/G2 but hRif1
was not visible on chromosomes in metaphase and ana-
phase; however, notably, speciﬁcally during early ana-
phase, hRif1 aligned along a subset of the midzone
microtubules between the separating chromosomes. In
telophase, hRif1 localized to chromosomes, and in inter-
phase, it was intranuclear. These results deﬁne a novel
subcellular localization behavior for hRif1 during the
cell cycle.
 
Introduction
 
Telomeres are the protective structures at the ends of eukaryotic
chromosomes that prevent chromosome termini from undergoing
unregulated degradation, recombination, and fusion. They are
specialized nucleoprotein complexes that consist of tandemly
repeated DNA sequences bound by various telomeric proteins
(Blackburn, 2001). Three different types of telomere-associated
proteins have been described: double-stranded telomeric DNA
binding proteins and their associated factors; single-stranded
telomeric DNA binding proteins and their associated factors;
and certain components of the general DNA damage response
pathways that also localize at telomeres (Blackburn, 2001;
Smogorzewska and De Lange, 2004).
Telomeres are maintained at well-controlled lengths by
factors that work to either lengthen or degrade telomeric DNA.
In most organisms, the telomeric repeat tracts are synthesized
by telomerase (Greider and Blackburn, 1985). The core com-
ponents of telomerase, a ribonucleoprotein complex, include a
reverse transcriptase and an RNA moiety that contains a short
template sequence for the telomeric DNA repeats (Blackburn,
2000). Proper telomere maintenance requires not only telomerase
activity but also the telomere-associated factors, which main-
tain telomere length homeostasis by regulating telomerase
recruitment, and the accessibility of telomeres to telomerase as
well as to exonucleases that act to degrade telomeres (Blackburn,
2001; Smogorzewska and De Lange, 2004).
From budding yeast to human cells, different sets of du-
plex telomeric DNA repeat–binding factors and their interacting
proteins have been identified and characterized. Although much
divergence has occurred in these proteins across species, there
are also significant levels of conservation. In budding yeasts
such as 
 
S. cerevisiae
 
, the telomeric protein Rif1p interacts in
vivo with Rap1p, the major telomeric double-stranded DNA
binding protein (Hardy et al., 1992; Wotton and Shore, 1997).
Rap1p also interacts with Rif2p in vivo, and mutations of
Rap1p disrupting its Rif1p and Rif2p binding, as well as dele-
tions of Rif1p and Rif2p proteins themselves, cause significant
telomere lengthening (Wotton and Shore, 1997). The Rif pro-
teins can also negatively regulate telomere length independent
of their recruitment by Rap1p (Levy and Blackburn, 2004).
In the fission yeast 
 
S. pombe
 
, duplex telomeric DNA re-
peats are bound by Taz1p, a homologue of the human TRF
proteins (Cooper et al., 1997), and 
 
S. pombe
 
 orthologues of
 
S. cerevisiae
 
 Rap1p and Rif1p have been identified (Chikashige
and Hiraoka, 2001; Kanoh and Ishikawa, 2001). spRap1p does
not directly bind to telomeric DNA and is apparently recruited
there by Taz1p. Although the 
 
S. pombe
 
 Rif1p negatively regulates
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telomere length and is found by ChIP analysis to be enriched at
telomeres, it differs from 
 
S. cerevisiae
 
 Rif1p in several aspects.
First, it interacts with Taz1p instead of spRap1p in a two-hybrid
assay. Second, immunostaining shows that it localizes hetero-
geneously in the nucleus in wild-type cells and was only seen
to translocate to telomeres after depletion of spRap1.
Although there is a human Rap1 orthologue (hRap1)
which localizes at telomeres and regulates telomere length like
 
S. pombe
 
 Rap1p, it does not bind human telomeric DNA by it-
self in vitro (Li et al., 2000; Li and de Lange, 2003). Instead,
hRap1 interacts in a yeast two-hybrid assay with TRF2 (Li et
al., 2000). TRF2 is one of two structurally related telomeric
proteins, TRF1 and TRF2, that each directly binds duplex hu-
man telomere repeats (Broccoli et al., 1997). Removal of TRF2
from telomeres by expressing a dominant negative allele of
TRF2 results in the loss of hRap1 at telomeres (Li et al., 2000).
Thus, hRap1 has apparently no detectable telomeric DNA bind-
ing capability and is thought to be tethered to telomeres through
its interaction with TRF2.
Here, we describe the identification and characterization
of a human Rif1 orthologue. We report that although the hRif1
protein does not detectably localize at normal telomeres, nor
interact with TRF1, TRF2, or hRap1, it can translocate to aber-
rant telomeres synthesized under the direction of a telomerase
RNA template mutant. Consistent with a recent report (Silver-
man et al., 2004), hRif1 similarly colocalizes to chromosomal-
wide sites of MMS-induced damage. Hence, hRif1 protein can
localize to DNA damage foci in response to both general and
telomere-specific chromosomal aberrancies. We also report
that during the cell cycle, hRif1 shows a novel subcellular dis-
tribution pattern: hRif1 becomes associated with chromatin at
telophase, but is absent from chromosomes in metaphase and
anaphase. Significantly, hRif1 aligns along a subset of the mid-
zone microtubules in early anaphase. Hence, we suggest that
hRif1 might also be involved in regulating microtubule struc-
tures at mitosis, possibly through modulation of microtubule
properties to help monitor appropriate chromosome segrega-
tion in mitosis.
 
Results
 
Cloning of hRif1
 
We identified a human orthologue of the yeast telomeric protein
Rif1 (Fig. 1 A). A partial human EST sequence that shares se-
quence homology with the NH
 
2
 
-terminal region of the 
 
S. cere-
visiae
 
 and 
 
S. pombe
 
 Rif1p was reported previously (Kanoh and
Ishikawa, 2001). We assembled a full-length hRif1 cDNA by
homology alignment with the partial sequence, exon prediction
from genomic sequences, and 5
 
 
 
- and 3
 
 
 
-rapid amplification of
cDNA ends (RACE). The full-length cDNA was then cloned by
RT-PCR. Multiple alternatively spliced forms of the 5
 
 
 
-untrans-
lated region were detected by the 5
 
 
 
-RACE analyses. However,
they all conform to the same initiator ATG sequence. The ORF
of the cDNAs encodes a protein of 2,472 aa. A COOH-terminal
region of the cDNA encoding 26 aa is alternatively spliced out,
resulting in a 2446–amino acid form (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200408181/DC1). RT-PCR
from different human cancer cell lines demonstrated that the
mRNA encoding this shorter protein product was much more
abundant than that encoding the longer product (unpublished
data). Sequence analysis of the hRif1 protein shows that it
shares sequence homology to 
 
S. cerevisiae
 
 and 
 
S. pombe
 
 Rif1 at
both NH
 
2
 
- and COOH-terminal regions (Fig. 1 A) but contains
no known protein motifs. Northern blotting analysis showed
that the hRif1 mRNA is ubiquitously expressed and alterna-
tively spliced in various human cancer cell lines, but the major
size differences of alternatively spliced mRNA all occurred out-
side the protein coding region (Fig. 1 B and Fig. 2 A). Multiple-
tissue Northern blots demonstrated that the hRif1 mRNA is
highly expressed in testis but is at very low levels in thymus and
uterus (Fig. 1 C), which is consistent with the expression pat-
tern of a mouse Rif1 orthologue reported recently (Adams and
McLaren, 2004).
 
Cellular effects of hRif1 depletion by 
siRNA
 
RIF1
 
 gene deletion in 
 
S. cerevisiae
 
 leads to substantially longer
telomeres but generally normal cell growth (Wotton and Shore,
Figure 1. Sequence conservation and expression of hRif1. (A) Schematic
representation of sequence similarities of Rif1 proteins. Percentage identities
are in black and percentage similarities are in red. A putative NLS is
marked in green. The alternatively spliced-out peptide of hRif1 is marked
in yellow. (B) Ubiquitous expression of hRif1 mRNA in human cancer cell
lines. 2  g of mRNAs from different cell lines were treated with glyoxal,
electrophoresed on a 20 cm   25 cm 0.8% agarose gel, transferred to a
Hybond NX membrane and hybridized with hRif1 or  -actin cDNA
probes. The bracket and arrowhead indicate groups of alternatively
spliced hRif1 mRNAs. (C) Expression of hRif1 mRNA in adult human tis-
sues. A multiple tissue Northern blot (CLONTECH Laboratories, Inc.) was
hybridized with hRif1 or  -actin cDNA probes. Separation of alternatively
spliced hRif1 mRNA was not as clear as in B because the mRNA electro-
phoresis was performed in a much smaller (6 cm   8 cm) 1% agarose
gel. The bracket and arrowhead indicate the groups of hRif1 mRNAs cor-
responding to those indicated in B. (D) Immunoblot of hRif1 protein with
antibody PAB2857. LOX cells were infected with lentiviruses expressing
siRNA sequences targeting hRif1 mRNA. 3 d after infection, 50  g of
whole cell extracts were analyzed by Western blot analysis and probed
with PAB2857. 
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1997). To test the cellular effects of hRif1 depletion we stably
knocked down hRif1 expression in tissue culture human cancer
cells and examined both cell growth and telomere length main-
tenance. We used a lentiviral delivery and expression system
(Li et al., 2004) to express hairpin siRNAs directed against sev-
eral different regions of the hRif1 mRNA (see Materials and
methods). As shown in Fig. 2 (A and B), six of the seven
siRNA constructs tested knocked down hRif1 expression to
varying extents. With both melanoma LOX cells and fibrosar-
coma HT1080 cells, we observed that cells with suppressed
levels of hRif1 grew significantly slower than the control cells,
whereas the siRNA sequence (construct 6042) that barely de-
creased the hRif1 mRNA level had little effect on cell growth
(Fig. 2 C). The effects on cell growth correlated generally well
with the degrees of hRif1 knockdown with the different si-
RNAs tested. We passaged these cells continuously in medium
selective for the lentiviral siRNA constructs for over 120 d and
examined telomere length by Southern blotting analysis. Un-
like in 
 
S. cerevisiae
 
, in which deletion of 
 
scRif1
 
 results in
longer telomeres (Hardy et al., 1992), no significant differences
in telomere length were detected in cell lines depleted of hRif1
compared with the mock-infected cells (Fig. S2, available at
http://www.jcb.org/cgi/content/full/jcb.200408181/DC1).
 
Association of hRif1 with aberrant 
telomeres
 
It has been demonstrated that at least a subset of 
 
S. cerevisiae
 
Rif1p protein colocalizes with scRap1p protein at telomeres by
immunofluorescence staining (Mishra and Shore, 1999; Smith
et al., 2003). To examine hRif1 localization, we developed af-
finity-purified rabbit pAbs against peptides aa 2106–2123 and
aa 2457–2472 of hRif1 (PAB2852 and PAB2857, respec-
tively). We note that the two peptide antibodies used in the
work recognize peptide sequences outside the alternatively
spliced region (Fig. 1 A and Fig. S1) and thus will recognize
both the longer (2472 aa) and the more abundant shorter (2446
aa) hRif1 proteins. For simplicity, in the paper we refer to
hRif1 to include both the longer and the shorter hRif1 protein
forms. Immunoblotting of whole cell extracts from control
cells and cells depleted of hRif1 by siRNA verified that both
antibodies recognized hRif1 (Fig. 1 D; not depicted). Immuno-
staining of tissue culture cells with each antibody showed
heterogeneous nuclear staining, but no evidence of the punc-
tate nuclear telomeric spots characteristic of TRF1, TRF2, or
hRap1 staining (Fig. 3 B, top). In addition, to examine whether
any fraction of hRif1 associates with known telomere binding
proteins, coimmunoprecipitation experiments were performed
between hRif1 and TRF1, TRF2 and hRap1 in multiple tissue
culture cell lines. Unlike the mouse Rif1 which was recently re-
ported to associate with mouse TRF2 (Adams and McLaren,
2004), no significant interactions were detected between Rif1
and TRF2, TRF1, or hRap1 (see Materials and methods; un-
published data). Together, these data suggest that hRif1 does
not localize to normal human telomeres.
Kanoh and Ishikawa (2001) reported that in 
 
S. pombe
 
Rif1p protein stained heterogeneously in the nucleus, but
moved to telomeres when 
 
spRap1
 
 gene was deleted. We con-
sidered the possibility that the SpRap1p depletion caused telo-
mere uncapping. For simplicity, the term telomere uncapping is
used in this work to refer to telomeres with different types and
degrees of abnormalities induced by the various methods spec-
ified in each context discussed. Such uncapping could have led
the translocation of SpRif1p to the resulting aberrant telomeres.
Therefore, we tested whether hRif1 localization in LOX and
HeLa human cancer cell lines was affected by uncapping telo-
meres in different ways. Overexpression of a dominant nega-
tive form of TRF2 has previously been reported to cause deple-
tion of telomere-associated TRF2 and telomere uncapping
(Karlseder et al., 1999; Takai et al., 2003), so we first at-
tempted to uncap telomeres either by siRNA-mediated deple-
tion of the telomere binding proteins TRF1, TRF2, or hRap1
(Fig. 3, A and B). We also uncapped telomeres by expressing a
telomerase RNA template mutant (MT-hTer) that directs syn-
thesis of deleterious telomeric repeats to the extreme tips of the
Figure 2. Impaired cell growth upon depletion of hRif1.
(A) Knockdown of hRif1 mRNA levels by siRNA treat-
ment. LOX cells were infected with lentiviruses expressing
hairpin siRNAs against different sequences within the
protein coding region of hRif1 mRNA. 2 d after infection,
40  g of total RNA from each cell line was hybridized
with hRif1 or GAPDH probes. Relative hRif1 levels were
determined by ImageQuant software using GAPDH as
the loading control. (B) Depletion of hRif1 protein levels
by siRNA. 50  g of whole cell extracts from each cell
line were probed with PAB2857 and  -tubulin antibod-
ies. siRNA treatment was performed as described in A.
(C) hRif1 depletion leads to cell growth inhibition in
HT1080 and LOX cells. HT1080 cells and LOX cells were
infected with lentiviral siRNA constructs at  95% efficien-
cies, as indicated by a GFP expressed from the same len-
tiviral vector. Cell numbers were counted every 3 d after
infection and cell counts are shown as mean   SD of
plates analyzed in triplicate. 
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telomeric repeat tracts (Kirk et al., 1997; Marusic et al., 1997).
After each treatment, we examined hRif1 localization.
In both LOX and HeLa cells, TRF1 and TRF2 depletion
each induced significant amounts of cell apoptosis, whereas
hRap1 depletion had little effect on cell growth (unpublished
data). We performed dual immunostaining of hRif1 and telo-
mere binding proteins TRF1 or TRF2 3 d after the introduction
of each siRNA in LOX cells and HeLa cells (i.e., after 
 
 
 
3 cell
population doublings; Fig. 3, A and B; not depicted). Although
by day 3 the cells infected with lentiviruses expressing hRap1,
TRF1, or TRF2 siRNA had increased numbers of hRif1 foci
per nucleus (mean numbers of 2.6, 3.8, and 3.6, respectively,
vs. 0.5 foci/nucleus in mock-infected control cells; 50 cells
were counted in each staining; Fig. 3, B and C), these foci sel-
dom colocalized with telomeres.
As an independent way of uncapping telomeres, we intro-
duced a lentiviral vector expressing a telomerase template mu-
tant, MT-hTer-47A (Li et al., 2004), in LOX and HeLa cells.
This mutant telomerase RNA synthesizes mutant telomeric re-
peats (Marusic et al., 1997; Li et al., 2004) that are predicted to
have lost binding affinity for TRF1 and -2. The control was
cells infected in parallel with a lentiviral expression vector ex-
pressing wild-type telomerase RNA (WT-hTER). hRif1 local-
ization was then examined via deconvolution microscopy. In
these control cells, the hRif1 staining pattern was indistinguish-
able from that of the mock-infected cells (unpublished data). In
contrast, in cells expressing 47A-hTer, hRif1 accumulated in
numerous distinct nuclear foci (mean number 34.4 foci per cell;
Fig. 3 C and Fig. 4 A). To investigate the nature of the foci,
we first performed coimmunostaining of hRif1 with antibody
against TRF2. TRF2 protein specifically localizes at human
telomeres (Broccoli et al., 1997). As shown in Fig. 4 A, the ma-
jority of hRif1 foci localized at or near telomeres. Because un-
capped telomeres can elicit cellular responses similar to dam-
aged DNA (Takai et al., 2003; Li et al., 2004), we then
performed dual staining of hRif1 with the DNA damage re-
sponse protein 53BP1. 53BP1 is known as a mediator of DNA
damage signaling; upon DNA damage, 53BP1 is recruited rap-
idly to sites of DNA double-strand breaks and forms discrete
nuclear foci (Schultz et al., 2000; Rappold et al., 2001). As
shown in Fig. 4 B, expression of hTER template mutant 47A
induced numerous 53BP1 foci in the nucleus. Almost all the
53BP1 foci overlapped with the hRif1 foci in these cells, indi-
cating that hRif1 localized at aberrant telomeres to produce
Figure 3. No detectable localization of hRif1 protein at
telomeres in normal cells or in cells depleted of hRap1,
TRF1, or TRF2 protein. (A) Western blot analysis of whole
cell extracts from LOX cells treated with lentiviruses ex-
pressing hairpin siRNAs against TRF1, TRF2, or hRap1.
(B) Immunofluorescence analysis of hRif1 protein in LOX
melanoma cells. LOX cells were infected with lentiviruses
expressing hairpin siRNAs against hRap1, TRF1, or TRF2.
3 d after infection, cells were fixed and stained with hRif1
antibody PAB2857 (red) and TRF1 or TRF2 antibodies
(green). A microscope (model Eclipse E600; Nikon) with
a 100  objective and a Coolsnap fx charge-coupled de-
vice camera and software (Roper Scientific) was used to
visualize the image. (C) Histogram showing the average
numbers of hRif1 foci per nucleus in LOX cells after treat-
ment with lentiviruses expressing hairpin siRNAs against
hRap1, TRF1, TRF2, or with lentiviruses expressing hTER
template mutant 47A. For each treatment, hRif1 foci in
 50 interphase cells were counted after immunofluores-
cence analysis and the average numbers per nucleus
were presented. 
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foci like those known to accumulate at DNA damage sites.
Dual staining with antibody against phosphorylated ATM pro-
tein (Bakkenist and Kastan, 2003), another early DNA damage
response sensor, and with antibody against hRif1 showed simi-
lar colocalization results (unpublished data).
We conclude that unlike 
 
S. cerevisiae
 
 Rif1p, hRif1 protein
does not associate with telomeres under normal conditions.
However, upon expression of a telomerase template mutant,
hRif1 and other DNA damage response factors efficiently trans-
locate to aberrant telomeres, suggesting that a significant por-
tion of the telomeres became uncapped and resembled DNA
damage after the mutant-template telomerase RNA expression.
Various reasons may account for why we did not detect signifi-
cant hRif1 localization at telomeres depleted of TRF1, TRF2, or
hRap1 by siRNA treatment. First, the degrees of depletion of
the aforementioned telomere binding factors (Fig. 3 A) might
not have been enough to induce significant telomere damage.
Second, depletion of the total levels of hRap1, TRF1, or TRF2
by RNA interference might have induced a cellular response
different from the telomere aberrancy that was induced by in-
corporation of mutant telomeric repeats or by expression of a
dominant negative TRF2. This interpretation is consistent with a
previous report showing a much milder increase in telomere as-
sociated DNA damage foci induced by siRNA-mediated TRF2
depletion compared with that induced by expression of a domi-
nant negative TRF2 (Takai et al., 2003). We suggest that when
TRF1, TRF2, and hRap1 proteins were depleted by RNA inter-
ference, the appearance of more hRif1 foci (most of which were
not at telomeres but colocalized with 53BP1; Fig. 3 B and not
depicted) might represent sites of chromosomal DNA breaks
caused by telomere fusions (known to be induced by TRF2 de-
pletion from telomeres; van Steensel et al., 1998) followed by
anaphase bridging and consequent chromosome breakage.
It has been demonstrated that telomeres deficient in
TRF2 binding induce a p53-dependent apoptotic response (Karl-
seder et al., 1999). To explore the role of p53 in the response of
hRif1 to mutant-sequence telomeres, we expressed telomerase
RNA template mutant 47A in two human colon cancer cell
lines that are isogenic except for their p53 status, HCT116
(p53WT) and HCT116 (p53
 
 
 
/
 
 
 
) (Bunz et al., 1998). Indirect
immunofluorescence staining demonstrated that hRif1 translo-
cated to discrete DNA damage foci as indicated by 53BP1 ac-
cumulation upon expression of template mutant 47A in both
cell lines with similar efficiency (Fig. 5). This result indicated
that hRif1 can respond to damaged telomeres without a re-
quirement for p53.
Figure 4. hRif1 accumulation on uncapped telomeres
synthesized by hTER template mutant 47A. Images were
analyzed with a Deltavision microscopy system using the
Deltavision SoftWorx resolve3D capture program and
collected as a stack of 0.2- m increments in the z axis.
After deconvolution, images were viewed with the Quick
Projection option. (A) hRif1 protein translocates to telo-
meres upon expression of hTER template mutant 47A
(47A-hTer). LOX cells were infected with lentiviruses ex-
pressing wild-type hTER (WT-hTER) or 47A-hTer. 3 d after
infection, cells were fixed and stained with TRF2 antibody
(green), hRif1 antibody PAB2852 (red), and DAPI (blue).
(B) hRif1 foci overlap with 53BP1 foci in LOX cells ex-
pressing 47A-hTer. Lentiviral infections were performed
as described in A. Cells were stained with 53BP1 anti-
body (green), hRif1 antibody (red), and DAPI (blue).
Bars, 10  m. 
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hRif1 overexpression in 
 
S. cerevisiae
 
 
interferes with telomere length 
maintenance
 
Having shown that human Rif1 can localize to telomeres when
they are made aberrant, we further investigated any potential
telomeric role of hRif1 by testing whether the protein retains
any evolutionarily conserved functional property across spe-
cies. Because 
 
S. cerevisiae
 
 Rif1p and Rif2p negatively regulate
telomere length (Wotton and Shore, 1997), we examined the ef-
fect of hRif1 overexpression on telomeric tract length in 
 
S. cer-
evisiae
 
 in wild-type yeast cells and in cells deleted for the
 
scRif1
 
 gene, 
 
scRif2
 
 gene, or both. The hRif1 full-length cDNA
was cloned into a yeast 2
 
 
 
-plasmid under the control of the
ADH1 promoter and transformed into a 
 
RIF1/rif1
 
, 
 
RIF2/rif2
 
heterozygous 
 
S. cerevisiae
 
 strain. The empty vector was used as
a control. The resulting strains were sporulated and spores with
desired genotypes overexpressing hRif1 or vector alone were
selected and passaged on plates consecutively for five streaks
(
 
 
 
125 population doublings) to allow telomere length to reach
equilibrium. We then compared the effects of human Rif1 over-
expression in the wild-type, 
 
 
 
rif1
 
,
 
 
 
 
 
rif2
 
 and 
 
 
 
rif1
 
 
 
rif2
 
 mutant
yeast cells. Data from five independent sporulation experiments
showed that overexpression of hRif1 in wild-type and 
 
 
 
rif2
 
strains led to significant telomere elongation; mean telomere
length averaged 330 and 910 bp longer, respectively. In con-
trast, overexpression of hRif1 in 
 
 
 
rif1
 
 or 
 
 
 
rif1
 
 
 
rif2
 
 strains did
not induce significant telomere length changes compared with
the vector control (changes 
 
 
 
120 bp; Fig. 6, A and B; Fig. S3,
available at http://www.jcb.org/cgi/content/full/jcb.200408181/
DC1). The finding that hRif1 overexpression perturbs telomere
length maintenance, in a manner specifically dependent on the
presence of the 
 
S. cerevisiae Rif1
 
 gene, suggests that hRif1 and
scRif1p proteins share at least some conserved functional inter-
actions that can directly or indirectly affect telomeres.
 
hRif1 is involved in the DNA damage 
response
 
It has recently been reported that hRif1 localizes to sites of
general DNA damage (Silverman et al., 2004). To confirm that
hRif1 plays a role in the general DNA damage response in the
human cell lines used in this work, we induced DNA damage in
LOX cells by treating the cells with MMS. Immunostaining of
endogenous hRif1 protein after MMS treatment for 1 h re-
vealed a punctate nuclear pattern for hRif1. Co-staining with
antibody against 53BP1 confirmed that these hRif1 foci colo-
calized with 53BP1 (Fig. 7 A). The appearance and size of
these hRif1 foci was reminiscent of the telomerically located
foci that had been induced by the 47A mutant-template telom-
erase RNA expression as described above. To verify indepen-
dently that the punctate nuclear pattern is specific to hRif1 pro-
tein, we also transfected LOX cells with a GFP-hRif1 fusion
protein expression construct and then subjected the cells to the
same 1-h MMS treatment. As shown in Fig. 7 B, GFP-hRif1
protein distributed heterogeneously in the nucleus in control
cells, whereas after MMS treatment, GFP-hRif1 protein trans-
Figure 5. hRif1 localizes on uncapped telomeres without
a requirement for wild-type p53. HCT116 cell lines with
the p53 locus wild type or disrupted, but which were oth-
erwise isogenic, were infected with lentiviruses expressing
47A-hTer. 5 d after infection, cells were fixed and stained
with 53BP1 antibody (green), hRif1 antibody PAB2852
(red), and DAPI (blue). Images were acquired with a
Deltavision microscopy system as described for Fig. 4.
Bars, 10  m.
Figure 6. hRif1 overexpression in S. cerevisiae perturbs telomere length
maintenance dependent on the presence of the scRif1 gene. (A) Southern
blot of telomeric restriction fragments in wild-type,  rif1,   rif2, and
 rif1 rif2 mutant yeast cells overexpressing hRif1 or the vector-alone control.
Genomic DNA was isolated from yeast cells, digested with XhoI, and
hybridized with a telomeric probe. (B) Histogram of bulk telomeric restric-
tion fragments in wild-type,  rif1,  rif2, and  rif1 rif2 mutant yeast cells
overexpressing hRif1 or the vector-alone control. Length of peak telomeric
restriction fragments was quantified with ImageQuant from five independent
sporulation experiments and is shown as mean   SD. 
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located to discrete foci that overlapped with 53BP1 protein.
These data confirm that hRif1 plays a role in the response to
general DNA damage. Hence, we suggest that the translocation
of hRif1 to aberrant telomeres that we have observed reflects
its role in a DNA damage response at uncapped telomeres.
 
Cell cycle–dependent levels and 
intracellular distribution of hRif1
 
In 
 
S. cerevisiae
 
, 
 
Rif1
 
 gene transcription displays periodic fluc-
tuation through the cell cycle, peaking during S phase (Cho et
al., 1998). In addition, scRif1p protein association with telo-
meric chromatin changes during the cell cycle; being minimal
at the beginning of S and G1 phase and maximal at mid/late S
and G2 phase, and decreasing around mitosis (Smith et al.,
2003). To further our understanding of hRif1, we examined
both the protein level and intracellular localization of hRif1
across the cell cycle.
To investigate whether hRif1 protein expression varies
during the cell cycle, we measured hRif1 protein steady-state
levels by Western blot analysis using synchronized populations
of T24 human bladder carcinoma cells. Parallel cultures of T24
cells were arrested at G0/G1 by contact inhibition. Cells were
then released from arrest by replating them at low density in
fresh medium (Chen et al., 1996). The cell-cycle distribution
profile of the synchronized culture at each time point was de-
termined by FACS analysis of DNA content. As shown in Fig.
8 A, hRif1 protein levels were low in G0, G1, and S phase, but
rose in G2/M phase. In cells arrested in M phase by nocodazole
treatment for 10 h, hRif1 accumulated at intermediate levels
(Fig. 8 A). The periodic variations of hRif1 protein expression
Figure 7. Accumulation of hRif1 protein at DNA damage foci induced by
MMS treatment. Images were acquired with a Deltavision microscopy sys-
tem as described for Fig. 4. (A) LOX cells were treated with 0.01% MMS
for 1 h, then fixed and immunostained with 53BP1 antibody (green) to vi-
sualize DNA damage foci, hRif1 antibody PAB2852 (red) to visualize the
endogenous hRif1 protein, and DAPI (blue). (B) GFP-hRif1 fusion protein
localizes to DNA damage foci induced by MMS treatment. LOX cells were
transfected with pEGFP-hRif1 expression construct. 2 d after transfection,
cells were treated with 0.01% MMS for 1 h, fixed and stained with 53BP1
antibody (red) and DAPI (blue). Bars, 10  m.
Figure 8. Cell cycle–regulated expression and intracellular distribution of
hRif1 protein. (A) hRif1 protein levels are regulated across the cell cycle.
Contact-inhibited T24 cells were released into the cell cycle for 0–33 h, as
indicated above the lanes. Whole cell extracts were probed with hRif1
antibody PAB2857 or  -tubulin antibody. DNA contents of synchronized
cells at different time points were determined by FACS analysis. Noc.,
cells were released into the cell cycle for 28 h and then treated with 0.3
 g/ml nocodazole for 10 h for a M phase block. (B) hRif1 dynamically
associates with chromatin during the cell cycle. LOX cells were fixed and
immunostained with  -tubulin antibody (green), hRif1 antibody (red), and
DAPI (blue). Images were analyzed with a Deltavision microscopy system
using the Deltavision SoftWorx resolve3D capture program and collected
as a stack of 0.2- m increments in the z axis. After deconvolution, an
image of a representative single section on the z axis saved as a Photo-
shop file is presented. Bars, 10  m.JCB • VOLUME 167 • NUMBER 5 • 2004 826
at different cell cycle stages were further analyzed with dual
immunostaining of hRif1 with the G2/M phase-specific protein
cyclin B. Cyclin B synthesis starts in the last one third of
S phase and reaches a maximum level in G2 and M phases
(Gong et al., 1993). As shown in Fig. S4 (available at http://
www.jcb.org/cgi/content/full/jcb.200408181/DC1), interphase
cells that showed no staining of cyclin B, and which were
judged on that basis to be in G1 or early- to mid-S phase, had
much lower levels of hRif1 staining compared with interphase
cells that had abundant cyclin B, which were in late S or G2
phase. Therefore, we conclude that the rise of hRif1 protein
levels in the cell cycle occurs in late S or G2 phase.
Because S. cerevisiae Rif1p protein dynamically associ-
ates with telomeric chromatin through the cell cycle (Smith et
al., 2003), we examined hRif1 localization at different cell cy-
cle stages, using indirect immunofluorescence staining of
endogenous hRif1 in LOX cells. In interphase cells, hetero-
geneous nuclear staining was observed for hRif1 protein. In
metaphase cells, hRif1 was notably absent from the condensed
chromosomes and instead was distributed widely throughout
the rest of the cell volume. In contrast, in telophase cells all the
visible hRif1 had become localized to the still condensed chro-
mosomes (Fig. 8 B).
Interestingly, during early anaphase, a significant amount
of hRif1 was observed to align along fiber-like structures that
were coincident with (or minimally, overlapped with) a subset
of the midzone microtubules located in between the two sets of
separating chromosomes (Fig. 9, A and B). Furthermore, hRif1
was on more fibers in early anaphase cells than in late anaphase
cells, indicating that this localization is a dynamic and regu-
Figure 9. hRif1 protein aligns along a subset of mid-
zone microtubules at anaphase. (A) Immunostaining of
hRif1 in early anaphase and late anaphase LOX cells us-
ing hRif1 antibody (red),  -tubulin antibody (green), and
DAPI (blue). Images were acquired with a Deltavision mi-
croscopy system as described in Fig. 8. (B) Enlarged im-
ages of early anaphase cells in A to show the alignment
of hRif1 along microtubules. (C) Schematic representation
of hRif1 deletion constructs used for analyses of telophase
chromosome association and anaphase midzone microtu-
bule colocalization. GFP-hRif1 deletion constructs were
transfected into LOX cells and immunostaining was per-
formed to determine their intracellular localization across
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lated process. Inspection of the separating chromosomes by de-
convolution microscopy excluded the possibility that any ana-
phase bridges were present and that the hRif1 might have been
associated with them. In addition, staining of anaphase cells
with antibodies against 53BP1 does not show the same pattern
(unpublished data). Hence, the hRif1 staining in this region
was not attributable to association with chromosome damage
sites. No localization to the midbody in cytokinesis was ob-
served. The same pattern of cell cycle–dependent association
of hRif1 with chromatin and midzone microtubules was cor-
roborated by immunofluorescence staining of LOX cells and
HeLa cells with two independent affinity-purified rabbit pAbs
raised against two different hRif1 peptide epitopes using either
PFA or methanol as fixation reagent, and also by transfecting
LOX cells with a GFP-hRif1 fusion protein (Fig. S5, available
at http://www.jcb.org/cgi/content/full/jcb.200408181/DC1).
These different methods of hRif1 detection all gave identical
results, confirming that this dynamic subcellular pattern was at-
tributable to hRif1.
To identify regions of hRif1 that are required for the telo-
phase reassociation with chromatin and the anaphase midzone
microtubule colocalization, we constructed various hRif1 dele-
tion constructs and fused them in-frame with the GFP. For the
hRif1 deletion construct lacking the hRif1 cognate NLS, we
added an SV40 T-antigen NLS to the NH2 terminus (Fig. 9 C).
Each deletion construct was then transfected into LOX cells
and its cellular distribution examined by fluorescence micros-
copy. As shown in Fig. 9 C, the GFP fusion proteins containing
full-length hRif1, hRif1
406-2446, hRif1
1355-2446, hRif1
1701-2446, and
hRif1
1924-2446, but not (NLS)hRif1
1-1308, retained the ability to
reassociate with chromatin at telophase. Hence, the 522–amino
acid COOH-terminal region of hRif1 is sufficient for this prop-
erty. In contrast, none of the deletion constructs tested colocal-
ized with midzone microtubules in anaphase cells, suggesting
that this colocalization requires both the NH2-terminal con-
served region (Fig. 1 A and Fig. 9 C, pink bars) and the COOH-
terminal region of hRif1.
Discussion
Here, we have reported the identification and characterization of
a human orthologue of Rif1 protein. The results provide evi-
dence that the human Rif1 protein binds uncapped telomeres, is
involved in the DNA damage response and associates with chro-
matin dynamically. Furthermore, we observed that hRif1 local-
izes along midzone microtubules specifically in early anaphase.
Findings made over the past several years have demon-
strated that DNA damage responses and telomere maintenance
cross paths. A growing list of proteins that have been defined
by their roles in the repair of double-strand DNA breaks, such
as Ku (Gravel et al., 1998; Hsu et al., 1999) and components of
the MRN DNA damage complex (MRX complex in yeast; Zhu
et al., 2000; Diede and Gottschling, 2001), are found at telo-
meres and are important for normal telomere maintenance in
eukaryotes ranging from yeasts to humans. It is thought that the
presence of the DNA damage machinery at telomeres may
monitor and regulate telomerase action on telomeres, perhaps
allowing cell cycle progression only after appropriate telomere
replication and integrity are assured. Rif1 protein is different
from the aforementioned DNA damage response proteins. In
the budding yeast S. cerevisiae, scRif1p is regarded as being
one of the integral members of the telomeric structural nucleo-
protein complex, and to be recruited to telomeres by the telo-
mere sequence-specific binding protein scRap1p to negatively
regulate telomere length (Hardy et al., 1992). In contrast, we
found that the human Rif1 counterpart has lost any detectable
ability to associate with normal telomeres or regulate telomere
length. Notably, the fission yeast and human Rif1 proteins have
a role in responding to telomere aberrancies.
Human Rif1 protein responded to general DNA damage
in human melanoma cells, as had also been reported by Silver-
man et al. (2004) for different cell lines. We found that deplet-
ing human cancer cells of Rif1 protein slowed their growth in
culture. It is known that loss of the DNA damage repair protein
Rad51 in vertebrate cells causes accumulation of chromosomal
breaks and loss of cell viability (Tsuzuki et al., 1996; Sonoda et
al., 1998). Therefore, we speculate that, like Rad51 and other
DNA damage response proteins, hRif1 may be essential for re-
pair of ongoing DNA damage and deficient hRif1 function may
lead to accumulation of unrepaired DNA damage that impairs
cell growth.
Evolution of Rif1
The results we observed with the human Rif1 orthologue pro-
vide a new perspective on the functions of Rif1 from an evolu-
tionary point of view. In summary, from S. cerevisiae through
S. pombe to humans, we see a progression in the tendency of
Rif1 protein to associate to aberrant or damaged telomeres
versus normal telomeres. In S. cerevisiae, scRif1p has been
thought to be recruited to telomeres mainly through its interac-
tion with the telomere binding protein scRap1p, and at least a
subset of scRif1p protein is colocalized with telomeres across
most if not the entire cell cycle (Mishra and Shore, 1999; Smith
et al., 2003). However, inspection of the association of scRif1p
and scRap1p proteins to telomeres during the cell cycle re-
vealed that scRif1p has an association pattern clearly different
from scRap1p (Smith et al., 2003): Notably, during S-phase,
the telomere association of scRif1p reaches its maximum value
in the cell cycle, whereas that of scRap1p decreases to its mini-
mum value. Because scRap1p binds to duplex telomere DNA
and provides a protective capping function, this pattern could
reflect a role of scRif1p in responding to changes in telomere
status. For example, scRif1p might be recruited to telomeres by
other proteins when scRap1p there is low in order to provide a
protective function for the Rap1-depleted telomeres, or scRif1p
may send a signal to promote scRap1p association with telo-
meres. Consistent with our hypothesis that scRif1p has an
elevated association with aberrant telomeres lacking scRap1p
binding, it has also been observed that the relative level of as-
sociation of scRif1p is slightly increased on the elongated and
partially deregulated telomeres in a heteroallelic tlc1-476A/
TLC1 S. cerevisiae strain, in which the association of scRap1p
with telomeres was simultaneously found to be decreased
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the chromatin immunoprecipitation method to be enriched at
telomeres, and interacts with another duplex telomeric DNA
binding protein Taz1 in a yeast two-hybrid assay, immunofluo-
rescence studies show that it has a heterogeneous staining pat-
tern in the nucleus and is not visualized at telomeres in wild-
type cells (Kanoh and Ishikawa, 2001). Instead, S. pombe
Rif1p is seen to translocate to telomeres only when the S.
pombe Rap1 gene is deleted. Because S. pombe Rap1p protein
normally localizes to telomeres and its deletion results in
greatly elongated telomeres (Chikashige and Hiraoka, 2001;
Kanoh and Ishikawa, 2001), we propose that spRap1p provides
capping function to telomeres in this yeast, and a substantial
amount of S. pombe Rif1p only associates with aberrant telo-
meres that were uncapped. In human cells, hRif1 has lost any
detectable association with normal telomeres or duplex telo-
meric DNA binding proteins TRF1, TRF2, or the human Rap1
orthologue hRap1, while keeping its function to respond to the
aberrant telomeric DNA synthesized from a template mutant of
telomerase RNA. Furthermore, hRif1 is involved in the general
DNA damage response. These findings suggest that the cellular
functions of hRif1 have diverged over evolution; however,
when we overexpressed hRif1 in S. cerevisiae, we did observe
interference in telomere length maintenance, which was specif-
ically dependent on the presence of the yeast Rif1 gene. There-
fore, it is of great interest to understand what aspects of the
Rif1 protein functions are conserved through evolution. It also
remains to be elucidated whether Rif1p proteins in S. cerevi-
siae and S. pombe play a role in the response to at least some
types of DNA damage.
Early anaphase–specific localization of 
hRif1 to midzone microtubules
While investigating the cell cycle–dependent subcellular distri-
bution of hRif1, we have discovered that hRif1 localizes along
a subset of the anaphase midzone microtubules, possibly deco-
rating the midzone of these microtubules, or even forming fi-
bers that overlap or coincide with these microtubules. The as-
sociation was maximal in early anaphase, with progressively
fewer microtubules showing this hRif1 association pattern as
anaphase progressed and the two sets of chromosomes further
separated. The data are consistent with hRif1 association with
midzone microtubules occurring in anaphase A and becoming
lost as cells enter anaphase B. Such microtubule association,
combined with the overall cell cycle pattern of localization of
hRif1, is novel and has not been reported for any other pro-
teins. This subcellular localization behavior differs, for exam-
ple, from that of chromosomal passenger proteins such as IN-
CENP and other proteins of the aurora kinase complex. Like
hRif1, these proteins are found on midzone microtubules in
anaphase and in the nucleus in interphase but, unlike hRif1, lo-
calize specifically to centromeres in metaphase and to the mid-
body at cytokinesis (Cooke et al., 1987; Higuchi and Uhlmann,
2003). The behavior of hRif1 also distinguishes it from human
chromatin protein Orc6, which is at kinetochores in metaphase,
the midzone in anaphase, and at the midbody in cytokinesis
(Prasanth et al., 2002), and from human chromatin repp86,
which is nuclear in G1/S, centrosomal at the onset of mitosis,
and localizes to the mitotic spindle in mitosis and to the mid-
body at cytokinesis (Heidebrecht et al., 2003).
We considered the possibility that hRif1 is being trans-
ported by microtubules to its subcellular targets. Because by
the end of telophase, all the visible hRif1 colocalizes with
the still-condensed chromosomes, specifically, hRif1 might be
transported back to the chromosomes on microtubules. How-
ever, the fact that there is no accumulation of hRif1 on chromo-
somes even during late anaphase compared with early ana-
phase argues against this model. An attractive but untested
possibility is that hRif1 is on microtubules where it serves to
monitor mitotic exit and control the progress of anaphase. One
observation consistent with this hypothesis is that in S. cerevi-
siae, chromosome loss rate increased  7.5- and  30-fold in
rif1 and rif1rif2 mutants, respectively, compared with wild-
type cells (Wotton and Shore, 1997). It was originally thought
that this increase is caused directly by impaired telomere func-
tion, which potentially leads to telomere fusions and the insta-
bility of any resulting dicentric chromosomes. Our results now
suggest that Rif1 proteins may in addition have a more direct
role in monitoring mitotic exit and hence chromosome segrega-
tion, possibly by modulating microtubule properties. We did
not observe a significant change in mitotic index in the LOX
melanoma cells depleted of hRif1 by multiple siRNA con-
structs (unpublished data). Given that it is unknown over what
range of concentrations hRif1 protein is functional in cells, it is
feasible that the residual levels of hRif1 in these cells are still
able to fulfill any function of monitoring mitotic exit. Thus,
cells with a conditional hRif1 gene knockout may better ad-
dress whether hRif1 affects mitotic progression. In addition to
hRif1’s midzone microtubule localization, it has been reported
that human TRF1 localizes to the mitotic spindle during mito-
sis (Nakamura et al., 2001). Tankyrase, a TRF1 interacting pro-
tein, has also been observed at centrosomes in mitotic cells
(Smith and de Lange, 1999). Therefore, the two seemingly un-
related structures, telomeres, and mitotic spindles, might have
some intrinsic functional connections with each other. Under-
standing these potential interplays will help elucidate new as-
pects of the orchestration of chromosome integrity and cell cy-
cle progression.
Materials and methods
Lentivirus infection
The lentiviral vector system was provided by D. Trono (University of
Geneva, Geneva, Switzerland; Zufferey et al., 1997). Recombinant len-
tiviruses were generated by transfecting pMD.G, pCMVDR8.91, and a
lentivector plasmid into 293T cells with lipofectamine 2000 (Invitrogen).
Lentivirus-containing medium was harvested 48 and 72 h after transfection
and filtered through 0.45- m filters. For lentiviral infection, cells were incu-
bated with virus-containing culture medium supplemented with 8  g/ml
polybrene for 8 h. For the cell growth experiments, 10
5 or 2   10
5 cells
were seeded onto 10-cm culture plates 3 d after lentiviral infection, and
the cell numbers were counted every 3 d.
Antibody production
Rabbit pAbs against peptide 2106-2123 NH2-(GC)ESDILQEDHHTSQKVEEP-
COOH (PAB2852) and peptide 2457-2472 NH2-(GC)KNLQSRWRSPSH-
ENSI-COOH (PAB2857) of hRif1 were generated (Bio-Synthesis, Inc.)
and affinity-purified against their corresponding peptide (Rockland
Immunochemicals).HRIF ON TELOMERES AND MIDZONE MICROTUBULES • XU AND BLACKBURN 829
RNA interference
Lentiviral hairpin siRNA expression vectors were constructed as described
previously (Li et al., 2004). The target sequences for the siRNA are: hRif1-
GACTCACATTTCCAGTCAA(6037), GCTGAGTAGTGCTGCTCTACA
(6038), GGAGAGACGCATTCTGCTG(6039), GAGGCAGTGAGGTGG-
GCAA(6041), GCTCTGGAGATGGGAATGCCA(6042), GAGAAAC-
CAGGTTCTGAAG(6053), GATGAAATCTCATCACCTG(6054); hRap1-
GATTTCATCTCCACGCAGTAC(6044); TRF1-GAATATTTGGTGATCCAAA
(6055), GGAACATGACAAACTTCATGA(6059); TRF2-GAGGATGAACTG-
TTTCAAG(6056), GCTGCTGTCATTATTTGTATC(6061). For cell growth
analysis, HT1080 cells and LOX cells were infected with lentiviral hairpin
siRNA constructs at  95% efficiency of infection as indicated by a GFP
expressed from the same lentiviral vector. For telomere length analysis and
immunofluorescent staining, the GFP gene in the lentiviral hairpin siRNA
vector was replaced by a puromycin resistance gene. Cells were infected
with corresponding lentiviruses and maintained in puromycin selection
medium.
RNA analysis
Total RNA was extracted using TRIzol reagent (Invitrogen). mRNA was iso-
lated using FastTrack 2.0 kit (Invitrogen). The 5 - and 3 -end of hRif1
cDNA was determined by the 5 - and 3 -RACE system (Invitrogen). hRif1
cDNA was amplified by PCR of first-strand cDNA synthesized with the Su-
perScript first-strand synthesis system for RT-PCR (Invitrogen).
For Northern blot analysis of hRif1, 2  g of mRNAs or 40  g of
total RNAs were treated with glyoxal (Sigma-Aldrich), electrophoresed
on a 0.8% or a 1% agarose gel, transferred to Hybond-NX membrane,
and hybridized with hRif1 or  -actin probes labeled with  -[
32P]-dCTP
using RediPrime II kit (Amersham Biosciences). The blots were analyzed
by phosphorimaging and quantified with the ImageQuant software
(Molecular Dynamics).
Immunoprecipitation and Western blot analysis
Cells were lysed in NP-40 lysis buffer (50 mM Tris, pH 8.0, 150 mM
NaCl, 2 mM EDTA, 1% NP-40, and protease inhibitors). After 20 min on
ice, the lysates were centrifuged at 14,000 rpm for 10 min and pre-
cleared by incubation with 40  l of protein A– or G–Sepharose beads
(Sigma-Aldrich) at 4 C for 30 min to obtain the whole cell extracts for im-
munoprecipitation. To examine the interaction of hRif1 with TRF1, TRF2,
and hRap1, coimmunoprecipitation of hRif1 with the endogenous TRF1,
TRF2, and hRap1 proteins, as well as with transiently transfected myc-
tagged TRF1, TRF2, and hRap1 proteins were performed. In brief, 1mg of
total protein of each whole cell extract was incubated with antibodies
against TRF1 (Novus), TRF2 (BD Transduction Laboratories) and hRap1
(Bethyl Laboratories) and protein A or G beads (Sigma-Aldrich) in a total
volume of 500  l for 4 h at 4 C. The beads were washed three times with
lysis buffer, resuspended in Laemmli loading buffer, and analyzed by SDS-
PAGE and Western blotting. For immunoprecipitation of hRif1 with ectopi-
cally expressed myc-tagged TRF1, TRF2, and hRap1 proteins, myc-tagged
TRF1, TRF2, and hRap1 expression constructs were transfected into 293
cells using lipofectamine 2000 (Invitrogen). Typically,  90% of cells
could be transfected. Whole cell extracts were made 2 d after transfec-
tion, and immunoprecipitation was performed using anti-myc antibody
9E10 (Covance).
For Western blot analysis, PAB2857 were used to detect hRif1 pro-
tein. The same blot was probed with anti– -tubulin (Sigma-Aldrich) anti-
body as loading controls.
Indirect immunofluorescence microscopy
Cells were grown on glass coverslips, fixed with 2% PFA in PBS, and per-
meabilized with 0.5% NP-40 in PBS. Immunostaining was performed
using primary antibodies against  -tubulin (Sigma-Aldrich), TRF1 (Novus
Biologicals), TRF2 (BD Transduction Laboratories), hRap1 (Bethyl Laborato-
ries), 53BP1 (BD Transduction Laboratories), cyclin B (BD Transduction
Laboratories), and two rabbit polyclonal peptide antibodies against hRif1,
followed by appropriate secondary antibodies conjugated with Alexa
Fluor 488 or 568 (Molecular Probes). DNA was visualized with 0.2  g/
ml DAPI.
Unless otherwise pointed out, all images were analyzed using a
Deltavision Restoration Microscopy system (Applied Precision) with a
60  objective and 1.5  magnifier. Images were acquired with the
Deltavision SoftWorx resolve3D capture program and collected as a
stack of 0.2- m increments in the z axis. After deconvolution, images
were viewed either with the Quick Projection option or as a single section
on the z axis.
Synchronization of T24 cells
Human bladder carcinoma T24 cells were synchronized at G0/G1 by
contact inhibition according to established protocols (Chen et al., 1996).
In brief, cells were seeded onto 10-cm culture plates. Fresh medium was
added to cultured cells every other day. After at least 7 d of confluence,
the cells were split onto 10-cm culture plates at a concentration of 10
6
cells per plate in fresh medium. Three plates were collected at each time
point: two for Western blot analysis and one for FACS analysis of DNA
content using propidium iodide staining.
GenBank accession No.
The GenBank/EMBL/DDBL accession nos. for the hRif1 cDNA reported in
this article are AY727910–AY727913.
Online supplemental material
Fig. S1 shows the amino acid sequence of hRif1. Fig. S2 shows telomere
length analysis of HT1080 human fibrosarcoma lines depleted of hRif1
protein. Fig. S3 shows telomere length analysis in wild-type,  rif1,  rif2,
and  rif1 rif2 mutant S. cerevisiae strains overexpressing hRif1 protein or
the vector-alone control. Fig. S4 shows that a higher level of hRif1 protein
is found in interphase LOX melanoma cells expressing cyclin B. Fig. S5
shows in LOX melanoma cells the midzone microtubule localization of the
transfected GFP-hRif1 fusion protein fixed with PFA and the endogenous
hRif1 protein fixed with methanol. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200408181/DC1.
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